A privately held biopharmaceutical company based in the United States. Its development and planned commercialization ...

By Emma Banks, chief executive at ramarketing If I had to describe 2025 in one phrase, it would be this: a year of two halves ...

Seattle, USA-based biotech Omeros Corp saw its shares leap 75.5% to $15.36 by close of trading Wednesday, as it revealed that ...

M&A news last week featured French pharma major Sanofi announcing an agreement to acquire US vaccine maker Dynavax ...

Neok Biotech’s $75 million series A venture round, which took the California-based biotech out of stealth mode, was not the ...

US rare disease specialist Agios Pharmaceuticals (Nasdaq: AGIO) has won approval for Aqvesme (mitapivat) to treat anemia in adults with alpha- or beta-thalassaemia, covering both ...

Japan’s Senju Pharmaceutical has announced that Avarept ophthalmic suspension 0.3% (motugivatrep), discovered and licensed by ...

French pharma major Sanofi (Euronext: SAN) has received a Complete Response Letter (CRL) from the US regulator for ...

Japanese pharma major Shionogi announced the conclusion of a joint research and development agreement and investment ...

German biosimilars specialist Formycon (FWB: FYB) has won US approval for Nufymco (ranibizumab), an interchangeable ...

Australian regulator the Therapeutic Goods Administration (TGA) has received an internationally recognized designation from ...